Evolutionary Genomics, Inc. Share-based Payment Arrangement, Expense
Evolutionary Genomics, Inc. reported Share-based Payment Arrangement, Expense of $78.19 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-10-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-10-21
- Evolutionary Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2022-09-30 was $78.19K, a 42.34% increase year-over-year.
- Evolutionary Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $78.19K, a 42.34% increase year-over-year.
- Evolutionary Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $56.46K, a 5.25% decline year-over-year.
- Evolutionary Genomics, Inc. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $54.93K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month |
|---|---|---|---|
| 2022-09-30 | $78.19K 10-Q · filed 2022-10-21 | $156.37K derived: sum of 2 quarters · filed 2022-10-21 | $212.83K 10-Q · filed 2022-10-21 |
| 2022-06-30 | $78.19K 10-Q · filed 2022-08-08 | $134.65K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $56.46K 10-Q · filed 2022-05-16 | ||
| 2021-09-30 | $54.93K 10-Q · filed 2022-10-21 | $109.86K derived: sum of 2 quarters · filed 2022-10-21 | $164.79K 10-Q · filed 2022-10-21 |
| 2021-06-30 | $54.93K 10-Q · filed 2022-08-08 | $109.86K 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $59.59K 10-Q · filed 2022-05-16 |